NY Univ. HIV/AIDS CRS (401) — New York, New York

NY Univ. HIV/AIDS CRS (401) is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

NY Univ. HIV/AIDS CRS (401) has participated in 10 clinical trials.

Therapeutic areas: HIV Infection, Tuberculosis, HIV-1 and Hepatitis C Co-Infection.

Sponsors: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NY Univ. HIV/AIDS CRS (401)?

NY Univ. HIV/AIDS CRS (401) has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NY Univ. HIV/AIDS CRS (401) conducted?

NY Univ. HIV/AIDS CRS (401) has 10 clinical trials on record. Their work covers HIV Infection, Tuberculosis, HIV-1 and Hepatitis C Co-Infection.

Is NY Univ. HIV/AIDS CRS (401) accredited by Crixeo Health?

NY Univ. HIV/AIDS CRS (401) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NY Univ. HIV/AIDS CRS (401)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.